Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Cancer Research Institute and the Canadian Cancer Trials Group announced a multi-year collaboration to develop and conduct clinical trials in immunotherapy.
read more
Baxter announced an agreement to acquire two hemostat and sealant products from Mallinckrodt: RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant.
read more
Sharp has completed the first phase in the development of its new USD $23m facility in Bethlehem, PA.
read more
Incyte and Syros Pharmaceuticals have entered into a target discovery, research collaboration and option agreement.
read more
Exelixis has entered into a collaboration and license agreement with StemSynergy for the discovery and development of novel oncology compounds targeting Casein Kinase 1 alpha.
read more
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
Datavant and Verge Genomics announced a strategic alliance to unlock the value of pharmaceutical datasets to accelerate drug discovery and development.
read more
Thursday, January 04, 2018
Beacon Discovery has entered into a collaboration agreement with Janssen Pharmaceuticals.
read more
Thursday, January 04, 2018
INC Research/inVentiv Health has changed its brand identity to Syneos Health effective January 4, 2018.
read more
Thursday, January 04, 2018
BLI has entered into a research collaboration and license agreement with Pfizer focused on optimizing BLI's proprietary Beacon Optofluidic platform.
read more
Wednesday, January 03, 2018
Bio-Techne has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures.
read more
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more
Wednesday, January 03, 2018
Pharmaceutical Product Development announced Colin Hill has been named to the company’s board of directors.
read more
Wednesday, January 03, 2018
McKesson Corporation has completed the previously announced acquisition of RxCrossroads.
read more
Wednesday, January 03, 2018
Orbis Biosciences has entered into an exclusive global license agreement leveraging its Precision Particle Fabrication technology.
read more